Nirupama K. Shevde

3.4k total citations · 1 hit paper
28 papers, 2.7k citations indexed

About

Nirupama K. Shevde is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Nirupama K. Shevde has authored 28 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Genetics and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Nirupama K. Shevde's work include Vitamin D Research Studies (12 papers), Estrogen and related hormone effects (11 papers) and Bone Metabolism and Diseases (9 papers). Nirupama K. Shevde is often cited by papers focused on Vitamin D Research Studies (12 papers), Estrogen and related hormone effects (11 papers) and Bone Metabolism and Diseases (9 papers). Nirupama K. Shevde collaborates with scholars based in United States, Netherlands and Italy. Nirupama K. Shevde's co-authors include J. Wesley Pike, J. Wesley Pike, Krista Dienger, Lee A. Zella, Sungtae Kim, Sung Tae Kim, Miwa Yamazaki, Mark B. Meyer, Jackie A. Fretz and Bryant G. Darnay and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Nirupama K. Shevde

28 papers receiving 2.6k citations

Hit Papers

Distinct molecular mechanism for initiating TRAF6 signalling 2002 2026 2010 2018 2002 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nirupama K. Shevde United States 22 1.3k 922 689 561 522 28 2.7k
Philippe Clément-Lacroix France 23 1.8k 1.3× 137 0.1× 882 1.3× 761 1.4× 250 0.5× 42 3.1k
Sun‐Kyeong Lee United States 29 2.2k 1.6× 123 0.1× 1.3k 1.9× 214 0.4× 476 0.9× 45 3.0k
Hiroyuki Mutoh Japan 23 1.2k 0.9× 241 0.3× 362 0.5× 1.2k 2.2× 197 0.4× 60 3.5k
Carmelo Mavilia Italy 27 572 0.4× 182 0.2× 515 0.7× 284 0.5× 584 1.1× 49 2.3k
Shunsuke Uehara Japan 23 1.8k 1.3× 89 0.1× 753 1.1× 341 0.6× 277 0.5× 52 2.7k
Deborah L. Galson United States 35 2.3k 1.7× 117 0.1× 1.4k 2.1× 268 0.5× 1.0k 2.0× 83 3.9k
Daniel C. Williams United States 8 1.0k 0.8× 125 0.1× 599 0.9× 440 0.8× 218 0.4× 12 1.8k
Jan Piet van Hamburg Netherlands 27 769 0.6× 609 0.7× 384 0.6× 181 0.3× 1.4k 2.7× 58 2.9k
Zhongjian Xie China 23 724 0.5× 475 0.5× 179 0.3× 174 0.3× 179 0.3× 61 1.8k
Teruhito Yamashita Japan 23 2.0k 1.5× 101 0.1× 942 1.4× 218 0.4× 278 0.5× 44 2.7k

Countries citing papers authored by Nirupama K. Shevde

Since Specialization
Citations

This map shows the geographic impact of Nirupama K. Shevde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nirupama K. Shevde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nirupama K. Shevde more than expected).

Fields of papers citing papers by Nirupama K. Shevde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nirupama K. Shevde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nirupama K. Shevde. The network helps show where Nirupama K. Shevde may publish in the future.

Co-authorship network of co-authors of Nirupama K. Shevde

This figure shows the co-authorship network connecting the top 25 collaborators of Nirupama K. Shevde. A scholar is included among the top collaborators of Nirupama K. Shevde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nirupama K. Shevde. Nirupama K. Shevde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shevde, Nirupama K.. (2012). Stem Cells: Flexible friends. Nature. 483(7387). S22–S26. 15 indexed citations
2.
Shevde, Nirupama K., et al.. (2012). Techniques in Embryoid Body Formation from Human Pluripotent Stem Cells. Methods in molecular biology. 946. 535–546. 11 indexed citations
3.
Squirrell, Jayne M., Kassondra Meyer, Nirupama K. Shevde, et al.. (2012). Endogenous Fluorescence Signatures in Living Pluripotent Stem Cells Change with Loss of Potency. PLoS ONE. 7(8). e43708–e43708. 16 indexed citations
4.
Zella, Lee A., Nirupama K. Shevde, Bruce W. Hollis, Nancy E. Cooke, & J. Wesley Pike. (2008). Vitamin D-Binding Protein Influences Total Circulating Levels of 1,25-Dihydroxyvitamin D3 but Does Not Directly Modulate the Bioactive Levels of the Hormone in Vivo. Endocrinology. 149(7). 3656–3667. 98 indexed citations
5.
Kim, Sung Tae, Miwa Yamazaki, Lee A. Zella, et al.. (2007). Multiple enhancer regions located at significant distances upstream of the transcriptional start site mediate RANKL gene expression in response to 1,25-dihydroxyvitamin D3. The Journal of Steroid Biochemistry and Molecular Biology. 103(3-5). 430–434. 51 indexed citations
6.
Pike, J. Wesley, Mark B. Meyer, Makoto Watanuki, et al.. (2007). Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptor. The Journal of Steroid Biochemistry and Molecular Biology. 103(3-5). 389–395. 59 indexed citations
7.
Fretz, Jackie A., Lee A. Zella, Sungtae Kim, Nirupama K. Shevde, & J. Wesley Pike. (2007). 1,25-Dihydroxyvitamin D3 induces expression of the Wnt signaling co-regulator LRP5 via regulatory elements located significantly downstream of the gene's transcriptional start site. The Journal of Steroid Biochemistry and Molecular Biology. 103(3-5). 440–445. 40 indexed citations
8.
Zella, Lee A., Sungtae Kim, Nirupama K. Shevde, & J. Wesley Pike. (2007). Enhancers located in the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. The Journal of Steroid Biochemistry and Molecular Biology. 103(3-5). 435–439. 29 indexed citations
9.
Fretz, Jackie A., Nirupama K. Shevde, Sujay Singh, Bryant G. Darnay, & J. Wesley Pike. (2007). Receptor Activator of Nuclear Factor-κB Ligand-Induced Nuclear Factor of Activated T Cells (C1) Autoregulates Its Own Expression in Osteoclasts and Mediates the Up-Regulation of Tartrate-Resistant Acid Phosphatase. Molecular Endocrinology. 22(3). 737–750. 24 indexed citations
10.
Fretz, Jackie A., Lee A. Zella, Sungtae Kim, Nirupama K. Shevde, & J. Wesley Pike. (2006). 1,25-Dihydroxyvitamin D3 Regulates the Expression of Low-Density Lipoprotein Receptor-Related Protein 5 via Deoxyribonucleic Acid Sequence Elements Located Downstream of the Start Site of Transcription. Molecular Endocrinology. 20(9). 2215–2230. 67 indexed citations
11.
Zella, Lee A., Sung Tae Kim, Nirupama K. Shevde, & J. Wesley Pike. (2006). Enhancers Located within Two Introns of the Vitamin D Receptor Gene Mediate Transcriptional Autoregulation by 1,25-Dihydroxyvitamin D3. Molecular Endocrinology. 20(6). 1231–1247. 131 indexed citations
12.
Yamamoto, Hironori, et al.. (2003). 2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 Potently Stimulates Gene-specific DNA Binding of the Vitamin D Receptor in Osteoblasts. Journal of Biological Chemistry. 278(34). 31756–31765. 76 indexed citations
13.
Pike, J. Wesley, Olga Barmina, Ching‐yi Chang, et al.. (2003). Synthetic LXXLL peptide antagonize 1,25‐dihydroxyvitamin D3‐dependent transcription. Journal of Cellular Biochemistry. 88(2). 252–258. 12 indexed citations
14.
Pike, J. Wesley, Hironori Yamamoto, & Nirupama K. Shevde. (2002). Vitamin D receptor–mediated gene regulation mechanisms and current concepts of vitamin D analog selectivity. Advances in Renal Replacement Therapy. 9(3). 168–174. 22 indexed citations
15.
Ye, Hong, Joseph R. Arron, Betty Lamothe, et al.. (2002). Distinct molecular mechanism for initiating TRAF6 signalling. Nature. 418(6896). 443–447. 550 indexed citations breakdown →
16.
Shevde, Nirupama K., Lori A. Plum, Margaret Clagett‐Dame, et al.. (2002). A potent analog of 1α,25-dihydroxyvitamin D 3 selectively induces bone formation. Proceedings of the National Academy of Sciences. 99(21). 13487–13491. 140 indexed citations
17.
Pathrose, Peterson, Olga Barmina, Ching‐yi Chang, et al.. (2002). Inhibition of 1,25-Dihydroxyvitamin D3-Dependent Transcription by Synthetic LXXLL Peptide Antagonists that Target the Activation Domains of the Vitamin D and Retinoid X Receptors. Journal of Bone and Mineral Research. 17(12). 2196–2205. 24 indexed citations
18.
Shevde, Nirupama K., et al.. (2001). IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor γ1. Proceedings of the National Academy of Sciences. 98(5). 2443–2448. 137 indexed citations
19.
Shevde, Nirupama K., et al.. (2000). Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proceedings of the National Academy of Sciences. 97(14). 7829–7834. 395 indexed citations
20.
Allegretto, Elizabeth A., Nirupama K. Shevde, Aihua Zou, et al.. (1995). Retinoid X Receptor Acts as a Hormone Receptor in Vivo to Induce a Key Metabolic Enzyme for 1,25-Dihydroxyvitamin D3. Journal of Biological Chemistry. 270(41). 23906–23909. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026